Eisai

Eisai is one of the leading pharmaceutical companies in the world engaged in the research and development of drugs in various therapeutic areas, which are characterized by a large number of unresolved medical issues, including oncology in neurology. The company is headquartered in. Japan

History

2023: Cyberattack

The Japanese pharmaceutical Eisai, a company specializing in the development and production of, and cancer drugs dementias other diseases, recently reported that it was faced with, attack programs extortioners which significantly affected the company's operations. This became known on June 8, 2023.

The attackers managed to encrypt some of the company's servers, which forced many Eisai IT systems, including logistics ones, to temporarily shut down. However, corporate websites and email continue to operate normally.

Eisai is a pharmaceutical company with $5.3 billion in annual revenue and more than 10,000 employees based in Tokyo. The company for June 2023 supports 9 production and 15 medical research units in Japan, the United Kingdom and the United States.

The cyber attack was detected on the night of June 3, Japanese time. The company immediately began investigating the incident with the help of external cybersecurity partners, and also created a special working group to quickly restore the functionality of internal systems.

The company also reported the incident to the relevant law enforcement agencies. According to Eisai representatives, the possibility of data leakage has not yet been confirmed, but is not excluded. It is also not yet known how this incident will affect the company's performance for fiscal year 2023.

So far, none of the large ransomware groups have claimed responsibility for this attack, but soon hackers will surely come out of the shadows. It is noteworthy that this is not the first case of a cyber attack on a Japanese pharmaceutical company.

In December 2021, Esai was also subjected to a ransomware attack. Then the AtomSilo group was involved in the cyber incident, which stole and published several of the company's databases on the network. However, this ransomware gang has already ceased operations^[1].

2021: Investing in a manufacturer of titanium rings that measure body temperature and heart rate, Oura

In early May 2021, the manufacturer of titanium rings measuring body temperature and heart rate raised $100 million. Thanks to this round of financing, the company Oura raised a total of $148.3 million. New investors were Temasek JAZZ Venture Partners and Eisai, they were also joined by investors Forerunner Ventures, Square MSD Capital, Marc Benioff Lifeline Ventures, Metaplanet Holdings and Next Ventures. More. here

Notes